
Pfizer considering cost cuts as Americans yawn at future COVID treatments and shots
Pfizer overestimated COVID vaccine uptake in 2023.

Pfizer considering cost cuts as Americans yawn at future COVID treatments and shotsPfizer overestimated COVID vaccine uptake in 2023.